Established in 2010, our company is a technology-based enterprise specializing in the research and development, production, sales, and service of in vitro rapid diagnostic reagents. We utilize monoclonal antibody technology, molecular immunology technology, nanotechnology, and microelectronics technology as a platform, accelerating product development to launch rapid, sensitive, specific, and accurate in vitro diagnostic products. All product performances and indicators meet industry standards. We adhere to the business philosophy of "quality, reputation, service and sincerity" and the quality policy of "perfect quality, sincere service, standardized management and innovation."